compounded tirzepatide with medicaid reddit Mounjaro vs Zepbound 2026: Cost, Side Effects, Weight Loss Minnesota doctor says FDA weight-loss

As of early 2026, multiple Phase 3 trials have reported positive topline results, regulatory submissions have been filed, and the FDA is reviewing orforglipron for an obesity indication with a target action date of April 10, 2026

When Should I Reach Out To My Doctor About Gaining Weight

Your loss depends on starting BMI, age, metabolic rate, concurrent medications, dietary adherence, physical activity, and genetic variants in GLP-1 and GIPR receptor pathways

Patients often experience nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when first starting the medication or increasing the dose

Notably, both aging and zinc deficiency are associated with an increased number of macrophages [217, 218] and monocytes [167, 172, 219, 220]